Related Experiment Video

Updated: Jun 26, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Differential requirement of mTOR in postmitotic tissues and tumorigenesis

Caterina Nardella1, Arkaitz Carracedo, Andrea Alimonti

  • 1Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

Science Signaling
|January 30, 2009
PubMed

Insights

Targeting the mammalian target of rapamycin (mTOR) pathway, crucial in PTEN-deficient prostate cancers, suppresses tumor growth. Inhibiting both mTORC1 and mTORC2 shows promise for treating these specific tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • The mammalian target of rapamycin (mTOR) pathway is a key regulator of cell growth and metabolism, frequently dysregulated in various cancers.
  • Loss of the tumor suppressor PTEN (phosphatase and tensin homolog deleted from chromosome 10) leads to hyperactivation of the PI3K/AKT/mTOR signaling pathway, a common event in prostate cancer.
  • mTOR functions within two distinct complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), each mediating different cellular processes.

Purpose of the Study:

  • To investigate the role of mTOR signaling in PTEN-deficient prostate cancer initiation and progression.
  • To evaluate the therapeutic potential of inhibiting mTOR, including both mTORC1 and mTORC2, in preclinical models of prostate cancer.

Main Methods:

  • Conditional inactivation of the mTOR gene in adult mouse prostate tissue.
  • Assessment of tumor initiation and progression following PTEN loss in the prostate.
  • Pharmacological inhibition of mTORC1.
  • In vitro studies on the differential requirement of mTOR in proliferating and transformed cells.

Main Results:

  • Conditional inactivation of mTOR in the adult mouse prostate did not significantly impact the normal tissue.
  • Inactivation of mTOR markedly suppressed Pten loss-induced prostate tumor initiation and progression.
  • The suppression of tumor growth by mTOR inactivation was more significant than that achieved by solely inhibiting mTORC1.
  • In vitro experiments revealed distinct dependencies on mTOR function for proliferating versus transformed cells.

Conclusions:

  • mTOR signaling is essential for the initiation and progression of prostate tumors driven by PTEN deficiency.
  • Targeting both mTORC1 and mTORC2, not just mTORC1, is a more effective strategy for treating PTEN-deficient prostate cancers.
  • These findings provide a strong rationale for developing dual mTORC1/mTORC2 inhibitors for the treatment of PTEN-deficient tumors with aberrant mTOR signaling.

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...